Skip to content

Supplier News

Watson unveils deal to acquire Actavis

Watson Pharmaceuticals Inc. plans to buy Actavis Group for 4.25 billion euros ($5.6 billion). Announced late Wednesday, the deal comes after recent buzz of a potential Watson acquisition of Switzerland-based Actavis by industry analysts.

Pepsi MAX kicks off ‘Field of Dreams’ promo

PepsiCo’s Pepsi MAX brand is giving baseball fans a chance to take the field with Major League Baseball legends in the Pepsi MAX MLB Field of Dreams program. The beverage giant said Tuesday that through June 15, fans across the country can go to MLB.com/PepsiMAX to votes for players on the American

Mylan, Dr. Reddy’s launch Zyprexa generics

Mylan Inc. and Dr. Reddy’s Laboratories have released olanzapine tablets, an antipsychotic medication, in six dosage strengths. The companies said Tuesday that their products, a generic version of Zyprexa from Eli Lilly and Co., come in strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg. Dr.

Bud Light Lime adds ‘Lime-A-Rita’

Anheuser-Busch is expanding its Bud Light lineup with Bud Light Lime Lime-a-Rita, which the company said gives a fresh twist to a classic summer cocktail, the margarita. Bud Light Lime also now sports new packaging.

AstraZeneca to acquire Ardea Biosciences

AstraZeneca plans to buy Ardea Biosciences Inc. in a cash deal valued at $1.26 billion. The companies said Monday that they expect the transaction to close in the second or third quarter of this year. The clinically most advanced product candidate of Ardea, a San Diego-based biotech firm focused on

Dr. Neuzil’s Irrigator nasal spray lands CDMA distribution

Dr. Neuzil’s Irrigator nasal cleansing spray has been added to the distribution channel of the Chain Drug Marketing Association (CDMA). Dr. Neuzil’s said Tuesday that under the agreement, more than 6,000 drug stores will now have access to its herbal-enhanced saline spray.

PhRMA names Lilly’s Lechleiter as chairman

John Lechleiter, chairman and chief executive officer of Eli Lilly and Co., has been elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA announced Lechleiter’s election to post on Friday at its annual meeting in Boston.